Qin-Gang Tan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Qin-Gang Tan has a total of 51 co-authors. Here are the top co-authors by number of shared publications:
Rui-Jing Ma
Department of Medicinal Chemistry, School of Pharmaceutical Sciences, Guilin Medical University, Guilin 541199, PR China
6 shared publicationsSheng-Nan Zhang
Pharmacy school, Guilin Medical University, Guilin 541100, PR China; Department of Pharmacy, The Second Affiliated Hospital of Guilin Medical University, Guilin 541199, PR China
5 shared publicationsHeng-Shan Wang
State Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources, Guangxi Normal University, Guilin 541004, PR China
4 shared publicationsHong-Zhi Song
Department of Medicinal Chemistry, Guilin Medical University, Guilin, P. R. China
4 shared publicationsJin Zeng
Guilin Medical University
3 shared publicationsWei Wei
Department of Medicinal Chemistry, School of Pharmaceutical Sciences, Guilin Medical University, Guilin 541199, PR China
3 shared publications
Latest Publications
- 18 March 2025
- Published by Wiley in Chemistry & Biodiversity
- Vol. 22 (7)
Ultra‐High‐Performance Liquid Chromatography‐Tandem Mass Spectrometry Combined With Network Pharmacology to Elucidate the Bioactive Ingredients and Potential Mechanism of Wu‐Teng Decoction for Treatment of Rheumatoid Arthritis
Wu‐Teng Decoction (WTD) is a significant in‐hospital preparation widely used in clinical practice to treat rheumatoid arthritis (RA) in China, however, its active substances and underlying mechanisms remain unclear. In this study, the chemical constituents of WTD were analyzed using ultra‐high‐performance liquid chromatography‐tandem mass spectrometry, identifying a total of 120 compounds, including flavonoids, phenylpropanoids, phenolic acids, alkaloids, etc. Subsequently, network pharmacology analyses revealed that 29 compounds were potential active compounds in WTD for the treatment of RA, as well as 48 core anti‐RA targets, including tumor necrosis factor‐α, V‐Akt murine thymoma viral oncogene homolog 1, and albumin. Further analysis suggested that WTD treats RA via the phosphoinositide 3‐kinase‐Akt, mitogen‐activated protein kinase, and Ras signaling pathways. Molecular docking analysis of the top five pivotal targets with the core active ingredients demonstrated suitable binding interactions at the active site of target proteins. The significant reduction of nitric oxide levels in lipopolysaccharides‐induced RAW264.7 cells validated the anti‐inflammation activity of WTD.
- 18 March 2025
- Published by Wiley in Chemistry & Biodiversity
- Vol. 22 (7)
Ultra‐High‐Performance Liquid Chromatography‐Tandem Mass Spectrometry Combined With Network Pharmacology to Elucidate the Bioactive Ingredients and Potential Mechanism of Wu‐Teng Decoction for Treatment of Rheumatoid Arthritis
Wu‐Teng Decoction (WTD) is a significant in‐hospital preparation widely used in clinical practice to treat rheumatoid arthritis (RA) in China, however, its active substances and underlying mechanisms remain unclear. In this study, the chemical constituents of WTD were analyzed using ultra‐high‐performance liquid chromatography‐tandem mass spectrometry, identifying a total of 120 compounds, including flavonoids, phenylpropanoids, phenolic acids, alkaloids, etc. Subsequently, network pharmacology analyses revealed that 29 compounds were potential active compounds in WTD for the treatment of RA, as well as 48 core anti‐RA targets, including tumor necrosis factor‐α, V‐Akt murine thymoma viral oncogene homolog 1, and albumin. Further analysis suggested that WTD treats RA via the phosphoinositide 3‐kinase‐Akt, mitogen‐activated protein kinase, and Ras signaling pathways. Molecular docking analysis of the top five pivotal targets with the core active ingredients demonstrated suitable binding interactions at the active site of target proteins. The significant reduction of nitric oxide levels in lipopolysaccharides‐induced RAW264.7 cells validated the anti‐inflammation activity of WTD.
- 7 March 2025
- Published by Elsevier in Fitoterapia
- Vol. 182, 106464
Diterpenoids and tannins from Cleidion brevipetiolatum
- 7 March 2025
- Published by Elsevier in Fitoterapia
- Vol. 182, 106464
Diterpenoids and tannins from Cleidion brevipetiolatum
- 26 November 2024
- Published by Elsevier in Fitoterapia
- Vol. 180, 106311
Tracheloside, the main constituent of the total lignan extract from Trachelospermi Caulis, inhibited rheumatoid arthritis via IL-17/MAPK signaling pathway
- 26 November 2024
- Published by Elsevier in Fitoterapia
- Vol. 180, 106311
Tracheloside, the main constituent of the total lignan extract from Trachelospermi Caulis, inhibited rheumatoid arthritis via IL-17/MAPK signaling pathway
- 1 July 2024
- Published by Springer Nature in Chemistry of Natural Compounds
- Vol. 60 (4) , 649-652
Triterpenoids from Glochidion eriocarpum
- 1 July 2024
- Published by Springer Nature in Chemistry of Natural Compounds
- Vol. 60 (4) , 649-652
Triterpenoids from Glochidion eriocarpum
- 1 July 2024
- Published by Springer Nature in Chemistry of Natural Compounds
- Vol. 60 (4) , 748-749
Chemical Compositions of Trachelospermum jasminoides
- 1 July 2024
- Published by Springer Nature in Chemistry of Natural Compounds
- Vol. 60 (4) , 748-749
Chemical Compositions of Trachelospermum jasminoides
- 6 November 2023
- Published by Elsevier in Fitoterapia
- Vol. 172, 105737
Aporphine and amide alkaloids from Illigera parviflora
- 6 November 2023
- Published by Elsevier in Fitoterapia
- Vol. 172, 105737
Aporphine and amide alkaloids from Illigera parviflora
- 23 September 2023
- Published by Elsevier in Tetrahedron Letters
- Vol. 130
Anti-inflammatory constituents from Bidens tripartita
- 23 September 2023
- Published by Elsevier in Tetrahedron Letters
- Vol. 130
Anti-inflammatory constituents from Bidens tripartita
- 12 March 2022
- Published by Elsevier in Phytochemistry
- Vol. 198, 113160
Dimeric Erythrina alkaloids as well as their key units from Erythrina variegata
- 12 March 2022
- Published by Elsevier in Phytochemistry
- Vol. 198, 113160
Dimeric Erythrina alkaloids as well as their key units from Erythrina variegata
- 28 December 2021
- Published by Georg Thieme Verlag KG in Planta Medica
- Vol. 88 (09/10) , 721-728
Anti-inflammatory Constituents from Caulis Trachelospermi
Caulis Trachelospermi, the stems with leaves of Trachelospermum jasminoides, is a well-known herbal drug of the Apocynaceae family recorded in the Chinese pharmacopeia and used for the treatment of inflammation-related diseases by ethnic minorities of China. The mechanism of anti-inflammatory activity and responsible constituents of T. jasminoides have not been well elucidated in previous studies. Preliminary investigation showed that both the water and the ethyl ester extracts of T. jasminoides exhibited potent inhibitory activity on nitric oxide (NO) production using lipopolysaccharide (LPS)-stimulated murine macrophages. Phytochemical investigation on these extracts afforded 23 compounds, including three new compounds (1 –3) identified on the basis of spectroscopic and mass spectrometric data. Anti-inflammatory bioassay showed that compounds 17, 18, 22, and 23 inhibited significantly the production of NO in a concentration-dependent manner. Further studies indicated that compound 23 inhibited significantly TNF-α and IL-6 produced by LPS-stimulated RAW 264.7 cells with good selectivity, as well as protein expression of iNOS in RAW 264.7 cells. These chemical constituents may contribute to the anti-inflammatory potential of T. jasminoides. # Dedicated to Professor Dr. Douglas Kinghorn on the occasion of his 75th birthday. Received: 12 September 2021 Accepted after revision: 25 November 2021 Publication Date: 28 December 2021 (online) © 2021. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- 28 December 2021
- Published by Georg Thieme Verlag KG in Planta Medica
- Vol. 88 (09/10) , 721-728
Anti-inflammatory Constituents from Caulis Trachelospermi
Caulis Trachelospermi, the stems with leaves of Trachelospermum jasminoides, is a well-known herbal drug of the Apocynaceae family recorded in the Chinese pharmacopeia and used for the treatment of inflammation-related diseases by ethnic minorities of China. The mechanism of anti-inflammatory activity and responsible constituents of T. jasminoides have not been well elucidated in previous studies. Preliminary investigation showed that both the water and the ethyl ester extracts of T. jasminoides exhibited potent inhibitory activity on nitric oxide (NO) production using lipopolysaccharide (LPS)-stimulated murine macrophages. Phytochemical investigation on these extracts afforded 23 compounds, including three new compounds (1 –3) identified on the basis of spectroscopic and mass spectrometric data. Anti-inflammatory bioassay showed that compounds 17, 18, 22, and 23 inhibited significantly the production of NO in a concentration-dependent manner. Further studies indicated that compound 23 inhibited significantly TNF-α and IL-6 produced by LPS-stimulated RAW 264.7 cells with good selectivity, as well as protein expression of iNOS in RAW 264.7 cells. These chemical constituents may contribute to the anti-inflammatory potential of T. jasminoides. # Dedicated to Professor Dr. Douglas Kinghorn on the occasion of his 75th birthday. Received: 12 September 2021 Accepted after revision: 25 November 2021 Publication Date: 28 December 2021 (online) © 2021. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- 21 September 2021
- Published by American Chemical Society (ACS) in The Journal of Organic Chemistry
- Vol. 86 (19) , 13381-13387
Colored Dimeric Alkaloids from the Barks of Erythrina variegata and Their Neuroprotective Effects
Five dimeric Erythrina alkaloids, named erythrivarines J–N, were isolated from the barks of Erythrina variegata L. (Fabaceae). The erythrivarines J–L featured a 6/6/5/6/6/5/6/6/6 ring system and super conjugated double bond systems, causing intense color from blue to wine red, while erythrivarines M–N looked orange. The structures of the isolated compounds were elucidated by 1D and 2D NMR experiments combined with MS and confirmed by the X-ray crystal diffraction technique. The performed bioassay using HEI-OC-1 cells revealed neuroprotective properties of erythrivarine N against the hearing loss causing antibiotics, neomycin.
- 21 September 2021
- Published by American Chemical Society (ACS) in The Journal of Organic Chemistry
- Vol. 86 (19) , 13381-13387
Colored Dimeric Alkaloids from the Barks of Erythrina variegata and Their Neuroprotective Effects
Five dimeric Erythrina alkaloids, named erythrivarines J–N, were isolated from the barks of Erythrina variegata L. (Fabaceae). The erythrivarines J–L featured a 6/6/5/6/6/5/6/6/6 ring system and super conjugated double bond systems, causing intense color from blue to wine red, while erythrivarines M–N looked orange. The structures of the isolated compounds were elucidated by 1D and 2D NMR experiments combined with MS and confirmed by the X-ray crystal diffraction technique. The performed bioassay using HEI-OC-1 cells revealed neuroprotective properties of erythrivarine N against the hearing loss causing antibiotics, neomycin.